US Patent Issued to TX MEDIC on July 7 for "Treatment of sepsis and hypercytokinemia" (Swedish Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,070, issued on July 7, was assigned to TX MEDIC AB (Viken, Sweden).

"Treatment of sepsis and hypercytokinemia" was invented by Lars Bruce (Viken, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to dextran sulfate, or a pharmaceutically acceptable salt thereof, in treatment of sepsis and hypercytokinemia."

The patent was filed on April 14, 2021, under Application No. 17/907,714.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12673070&OS=12673070&RS=126730...